[1] Kim JE, Chen J, Lou Z. DBC1 is a negative regulator of SIRT1 [J]. Nature, 2008, 451(7178): 583-586.
[2] Ren Z, He H, Zuo Z, et al. The role of different SIRT1-mediated signaling pathways in toxic injury [J]. Cell Mol Biol Lett, 2019, 24: 36.
[3] Yang X, Sun X, Wu J, et al. Regulation of the SIRT1 signaling pathway in NMDA-induced Excitotoxicity [J]. Toxicol Lett, 2020, 322: 66-76.
[4] Ding M, Lei J, Han H, et al. SIRT1 protects against myocardial ischemia-reperfusion injury via activating eNOS in diabetic rats [J]. Cardiovasc Diabetol, 2015, 14: 143.
[5] Singh P, Hanson PS, Morris CM. SIRT1 ameliorates oxidative stress induced neural cell death and is down-regulated in Parkinson’s disease [J]. BMC Neurosci, 2017, 18(1): 46.
[6] Liu T, Ma X, Ouyang T, et al. SIRT1 reverses senescence via enhancing autophagy and attenuates oxidative stress-induced apoptosis through promoting p53 degradation [J]. Int J Biol Macromol, 2018, 117: 225-234.
[7] Zou Zh, Zhao ZhH, Dong YSh, et al. SIRT1 inhibits oxidative stress in PC12 cells by promoting deacetylation of eIF2α [J]. Chinese Journal of Neuroanatomy, 2019, 35(3): 288-292. (in Chinese)
邹正,赵忠惠,董玉书,等. SIRT1通过促进eIF2α去乙酰化抑制PC12细胞氧化应激反应 [J]. 神经解剖学杂志, 2019, 35(3): 288-292.
[8] Li Y, Xu W, McBurney MW, et al. SirT1 inhibition reduces IGF-Ⅰ/IRS-2/Ras/ERK1/2 signaling and protects neurons [J]. Cell Metab, 2008, 8(1): 38-48.
[9] Kawai Y, Garduno L, Theodore M, et al. Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization [J]. J Biol Chem, 2011, 286(9): 7629-7640.
[10] Zhang XF, Ding MJ, Cheng C, et al. Andrographolide attenuates oxidative stress injury in cigarette smoke extract exposed macrophages through inhibiting SIRT1/ERK signaling [J]. Int Immunopharmacol, 2020, 81: 106230.
[11] Lynch CJ, Shah ZH, Allison SJ, et al. SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53 [J]. PLoS One, 2010, 5(10): e13502.
[12] Shah ZH, Ahmed SU, Ford JR, et al. A deacetylase-deficient SIRT1 variant opposes full-length SIRT1 in regulating tumor suppressor p53 and governs expression of cancer-related genes [J]. Mol Cell Biol, 2012, 32(3): 704-716.
[13] Deota S, Chattopadhyay T, Ramachandran D, et al. Identification of a tissue-restricted isoform of SIRT1 defines a regulatory domain that encodes specificity [J]. Cell Rep, 2017, 18(13): 3069-3077.
[14] Zhao W, Zhao J, Hou M, et al. HuR and TIA1/TIAL1 are involved in regulation of alternative splicing of SIRT1 premRNA [J]. Int J Mol Sci, 2014, 15(2): 2946-2958.
[15] Deschenes M, Chabot B. The emerging role of alternative splicing in senescence and aging [J]. Aging Cell, 2017, 16(5): 918-933.
|